Original Research
Published on 08 Oct 2025
Safety profile of complement C5 inhibitors and FcRn inhibitors in the treatment of myasthenia gravis: analysis of the FAERS database and disease-gene interaction network
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
- 367 views